Abiopharma

News list

Fey Lawrence 🟡 adjusted position in 0 shares (1 derivative) of Vivid Seats Inc. (SEAT) Transaction Date: Aug 12, 2026 | Filing ID: 352283

Full text

News bot Aug. 14, 2026, 8:20 p.m.
🔍 Fey Lawrence (Executive)

Company: Vivid Seats Inc. (SEAT)

Report Date: 2026-08-12
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 1,854
- Total shares sold: 1,854
Detailed Transactions and Holdings:
- Acquired 1,854 shares of Class A Common Stock (Direct)
  Date: 2026-08-12 | Code: M | equity_swap_involved: false | shares_owned_after: 277,041.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 1,854 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-12 | Code: M | equity_swap_involved: false | shares_owned_after: 5,564.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A common stock.
- F2: One-third of the RSUs vested on May 12, 2025. The remainder of the RSUs vest in equal quarterly installments such that they will be fully vested on May 12, 2027. The RSUs do not have an expiration date.